JHM Schellens
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 11
- Neutropenia and Cancer Infections 4
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 3
- Drug Transport and Resistance Mechanisms 2
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- Jaap Verweij (10 shared papers)G. Stoter (6 shared papers)M de Boer-Dennert (6 shared papers)A.S.T. Planting (4 shared papers)G.J. Creemers (3 shared papers)Jun Ma (2 shared papers)Hilde Rosing (2 shared papers)Jos H. Beijnen (1 shared paper)
- Journals
- British Journal of Cancer (10 papers)Clinical Pharmacology & Therapeutics (2 papers)Anti-Cancer Drugs (1 paper)Bioanalysis (1 paper)Journal of Oncology Pharmacy Practice (2 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
JHM Schellens
16 papers receiving 607 citations
Peers
Comparison fields: 5 of 63
- Oncology 448
- Toxicology 45
- Molecular Biology 412
- Pathology and Forensic Medicine 78
- Pharmacology 29
Countries citing papers authored by JHM Schellens
This map shows the geographic impact of JHM Schellens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JHM Schellens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JHM Schellens more than expected).
Fields of papers citing papers by JHM Schellens
This network shows the impact of papers produced by JHM Schellens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JHM Schellens. The network helps show where JHM Schellens may publish in the future.
Co-authors
The 25 scholars most cited alongside JHM Schellens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 122 | |
| 2 | 1997 | 120 | |
| 3 | 1996 | 113 | |
| 4 | 1998 | 51 | |
| 5 | 1996 | 37 | |
| 6 | 1994 | 29 | |
| 7 | 1995 | 29 | |
| 8 | 1997 | 24 | |
| 9 | 2000 | 24 | |
| 10 | 2007 | 23 | |
| 11 | 1998 | 18 | |
| 12 | 2012 | 12 | |
| 13 | 1996 | 10 | |
| 14 | 2008 | 9 | |
| 15 | 1999 | 3 | |
| 16 | 2009 | 2 |
About JHM Schellens
JHM Schellens is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Surgery and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 626 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Chemotherapy-induced organ toxicity mitigation (4 papers), Neutropenia and Cancer Infections (4 papers), Lung Cancer Research Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Pharmaceutical studies and practices (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Intraperitoneal and Appendiceal Malignancies (1 paper). The work is most often cited by research in Oncology (448 citations), Toxicology (45 citations), Molecular Biology (412 citations), Pathology and Forensic Medicine (78 citations) and Pharmacology (29 citations). JHM Schellens has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jaap Verweij, G. Stoter, M de Boer-Dennert, A.S.T. Planting, G.J. Creemers, Jun Ma, Hilde Rosing, Jos H. Beijnen, E. van Meerten and Mirna McDonald. Their work appears in journals such as British Journal of Cancer, Clinical Pharmacology & Therapeutics, Anti-Cancer Drugs, Bioanalysis and Journal of Oncology Pharmacy Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.